The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Nucleic Acid Blood Screening Market Research Report 2025
Synopsis
Blood screening, also known as blood source screening, refers to the screening of blood donors and plasma apheresis groups in order to ensure the safety of clinical blood and the quality of blood products, and to prevent blood-borne pathogen-positive plasma from being directly imported into patients or used in the production of blood products. Screening performed.
The global Nucleic Acid Blood Screening market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Nucleic Acid Blood Screening is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Nucleic Acid Blood Screening is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Nucleic Acid Blood Screening include Roche, Grifols Diagnostic Solutions, PerkinElmer, KHB, Bacme Bio, Daan Gene, Wantai Biotechnology, Sansure Biotech and Zhuhai Livzon Reagents, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Nucleic Acid Blood Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nucleic Acid Blood Screening.
Report Scope
The Nucleic Acid Blood Screening market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nucleic Acid Blood Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nucleic Acid Blood Screening manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Grifols Diagnostic Solutions
PerkinElmer
KHB
Bacme Bio
Daan Gene
Wantai Biotechnology
Sansure Biotech
Zhuhai Livzon Reagents
Bio-Rad Laboratories
Horiba
Thermo Fisher Scientific
bioMerieux
Danaher
Abbott
BD
Mindray
Segment by Type
Blood Screening Equipment
blood Screening Reagents
Segment by Application
Blood Center
Central Blood Station
Central Blood Bank
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nucleic Acid Blood Screening manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nucleic Acid Blood Screening in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Blood screening, also known as blood source screening, refers to the screening of blood donors and plasma apheresis groups in order to ensure the safety of clinical blood and the quality of blood products, and to prevent blood-borne pathogen-positive plasma from being directly imported into patients or used in the production of blood products. Screening performed.
The global Nucleic Acid Blood Screening market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Nucleic Acid Blood Screening is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Nucleic Acid Blood Screening is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Nucleic Acid Blood Screening include Roche, Grifols Diagnostic Solutions, PerkinElmer, KHB, Bacme Bio, Daan Gene, Wantai Biotechnology, Sansure Biotech and Zhuhai Livzon Reagents, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Nucleic Acid Blood Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nucleic Acid Blood Screening.
Report Scope
The Nucleic Acid Blood Screening market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nucleic Acid Blood Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nucleic Acid Blood Screening manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Grifols Diagnostic Solutions
PerkinElmer
KHB
Bacme Bio
Daan Gene
Wantai Biotechnology
Sansure Biotech
Zhuhai Livzon Reagents
Bio-Rad Laboratories
Horiba
Thermo Fisher Scientific
bioMerieux
Danaher
Abbott
BD
Mindray
Segment by Type
Blood Screening Equipment
blood Screening Reagents
Segment by Application
Blood Center
Central Blood Station
Central Blood Bank
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nucleic Acid Blood Screening manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nucleic Acid Blood Screening in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Nucleic Acid Blood Screening Market Overview
1.1 Product Overview and Scope of Nucleic Acid Blood Screening
1.2 Nucleic Acid Blood Screening Segment by Type
1.2.1 Global Nucleic Acid Blood Screening Market Value Comparison by Type (2024-2030)
1.2.2 Blood Screening Equipment
1.2.3 blood Screening Reagents
1.3 Nucleic Acid Blood Screening Segment by Application
1.3.1 Global Nucleic Acid Blood Screening Market Value by Application: (2024-2030)
1.3.2 Blood Center
1.3.3 Central Blood Station
1.3.4 Central Blood Bank
1.4 Global Nucleic Acid Blood Screening Market Size Estimates and Forecasts
1.4.1 Global Nucleic Acid Blood Screening Revenue 2019-2030
1.4.2 Global Nucleic Acid Blood Screening Sales 2019-2030
1.4.3 Global Nucleic Acid Blood Screening Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Nucleic Acid Blood Screening Market Competition by Manufacturers
2.1 Global Nucleic Acid Blood Screening Sales Market Share by Manufacturers (2019-2024)
2.2 Global Nucleic Acid Blood Screening Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Nucleic Acid Blood Screening Average Price by Manufacturers (2019-2024)
2.4 Global Nucleic Acid Blood Screening Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nucleic Acid Blood Screening, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nucleic Acid Blood Screening, Product Type & Application
2.7 Nucleic Acid Blood Screening Market Competitive Situation and Trends
2.7.1 Nucleic Acid Blood Screening Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nucleic Acid Blood Screening Players Market Share by Revenue
2.7.3 Global Nucleic Acid Blood Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nucleic Acid Blood Screening Retrospective Market Scenario by Region
3.1 Global Nucleic Acid Blood Screening Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Nucleic Acid Blood Screening Global Nucleic Acid Blood Screening Sales by Region: 2019-2030
3.2.1 Global Nucleic Acid Blood Screening Sales by Region: 2019-2024
3.2.2 Global Nucleic Acid Blood Screening Sales by Region: 2025-2030
3.3 Global Nucleic Acid Blood Screening Global Nucleic Acid Blood Screening Revenue by Region: 2019-2030
3.3.1 Global Nucleic Acid Blood Screening Revenue by Region: 2019-2024
3.3.2 Global Nucleic Acid Blood Screening Revenue by Region: 2025-2030
3.4 North America Nucleic Acid Blood Screening Market Facts & Figures by Country
3.4.1 North America Nucleic Acid Blood Screening Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Nucleic Acid Blood Screening Sales by Country (2019-2030)
3.4.3 North America Nucleic Acid Blood Screening Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nucleic Acid Blood Screening Market Facts & Figures by Country
3.5.1 Europe Nucleic Acid Blood Screening Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Nucleic Acid Blood Screening Sales by Country (2019-2030)
3.5.3 Europe Nucleic Acid Blood Screening Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Nucleic Acid Blood Screening Market Facts & Figures by Country
3.6.1 Asia Pacific Nucleic Acid Blood Screening Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Nucleic Acid Blood Screening Sales by Country (2019-2030)
3.6.3 Asia Pacific Nucleic Acid Blood Screening Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Nucleic Acid Blood Screening Market Facts & Figures by Country
3.7.1 Latin America Nucleic Acid Blood Screening Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Nucleic Acid Blood Screening Sales by Country (2019-2030)
3.7.3 Latin America Nucleic Acid Blood Screening Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Nucleic Acid Blood Screening Market Facts & Figures by Country
3.8.1 Middle East and Africa Nucleic Acid Blood Screening Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Nucleic Acid Blood Screening Sales by Country (2019-2030)
3.8.3 Middle East and Africa Nucleic Acid Blood Screening Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nucleic Acid Blood Screening Sales by Type (2019-2030)
4.1.1 Global Nucleic Acid Blood Screening Sales by Type (2019-2024)
4.1.2 Global Nucleic Acid Blood Screening Sales by Type (2025-2030)
4.1.3 Global Nucleic Acid Blood Screening Sales Market Share by Type (2019-2030)
4.2 Global Nucleic Acid Blood Screening Revenue by Type (2019-2030)
4.2.1 Global Nucleic Acid Blood Screening Revenue by Type (2019-2024)
4.2.2 Global Nucleic Acid Blood Screening Revenue by Type (2025-2030)
4.2.3 Global Nucleic Acid Blood Screening Revenue Market Share by Type (2019-2030)
4.3 Global Nucleic Acid Blood Screening Price by Type (2019-2030)
5 Segment by Application
5.1 Global Nucleic Acid Blood Screening Sales by Application (2019-2030)
5.1.1 Global Nucleic Acid Blood Screening Sales by Application (2019-2024)
5.1.2 Global Nucleic Acid Blood Screening Sales by Application (2025-2030)
5.1.3 Global Nucleic Acid Blood Screening Sales Market Share by Application (2019-2030)
5.2 Global Nucleic Acid Blood Screening Revenue by Application (2019-2030)
5.2.1 Global Nucleic Acid Blood Screening Revenue by Application (2019-2024)
5.2.2 Global Nucleic Acid Blood Screening Revenue by Application (2025-2030)
5.2.3 Global Nucleic Acid Blood Screening Revenue Market Share by Application (2019-2030)
5.3 Global Nucleic Acid Blood Screening Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Nucleic Acid Blood Screening Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Roche Nucleic Acid Blood Screening Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Grifols Diagnostic Solutions
6.2.1 Grifols Diagnostic Solutions Corporation Information
6.2.2 Grifols Diagnostic Solutions Description and Business Overview
6.2.3 Grifols Diagnostic Solutions Nucleic Acid Blood Screening Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Grifols Diagnostic Solutions Nucleic Acid Blood Screening Product Portfolio
6.2.5 Grifols Diagnostic Solutions Recent Developments/Updates
6.3 PerkinElmer
6.3.1 PerkinElmer Corporation Information
6.3.2 PerkinElmer Description and Business Overview
6.3.3 PerkinElmer Nucleic Acid Blood Screening Sales, Revenue and Gross Margin (2019-2024)
6.3.4 PerkinElmer Nucleic Acid Blood Screening Product Portfolio
6.3.5 PerkinElmer Recent Developments/Updates
6.4 KHB
6.4.1 KHB Corporation Information
6.4.2 KHB Description and Business Overview
6.4.3 KHB Nucleic Acid Blood Screening Sales, Revenue and Gross Margin (2019-2024)
6.4.4 KHB Nucleic Acid Blood Screening Product Portfolio
6.4.5 KHB Recent Developments/Updates
6.5 Bacme Bio
6.5.1 Bacme Bio Corporation Information
6.5.2 Bacme Bio Description and Business Overview
6.5.3 Bacme Bio Nucleic Acid Blood Screening Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bacme Bio Nucleic Acid Blood Screening Product Portfolio
6.5.5 Bacme Bio Recent Developments/Updates
6.6 Daan Gene
6.6.1 Daan Gene Corporation Information
6.6.2 Daan Gene Description and Business Overview
6.6.3 Daan Gene Nucleic Acid Blood Screening Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Daan Gene Nucleic Acid Blood Screening Product Portfolio
6.6.5 Daan Gene Recent Developments/Updates
6.7 Wantai Biotechnology
6.6.1 Wantai Biotechnology Corporation Information
6.6.2 Wantai Biotechnology Description and Business Overview
6.6.3 Wantai Biotechnology Nucleic Acid Blood Screening Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Wantai Biotechnology Nucleic Acid Blood Screening Product Portfolio
6.7.5 Wantai Biotechnology Recent Developments/Updates
6.8 Sansure Biotech
6.8.1 Sansure Biotech Corporation Information
6.8.2 Sansure Biotech Description and Business Overview
6.8.3 Sansure Biotech Nucleic Acid Blood Screening Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sansure Biotech Nucleic Acid Blood Screening Product Portfolio
6.8.5 Sansure Biotech Recent Developments/Updates
6.9 Zhuhai Livzon Reagents
6.9.1 Zhuhai Livzon Reagents Corporation Information
6.9.2 Zhuhai Livzon Reagents Description and Business Overview
6.9.3 Zhuhai Livzon Reagents Nucleic Acid Blood Screening Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Zhuhai Livzon Reagents Nucleic Acid Blood Screening Product Portfolio
6.9.5 Zhuhai Livzon Reagents Recent Developments/Updates
6.10 Bio-Rad Laboratories
6.10.1 Bio-Rad Laboratories Corporation Information
6.10.2 Bio-Rad Laboratories Description and Business Overview
6.10.3 Bio-Rad Laboratories Nucleic Acid Blood Screening Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Bio-Rad Laboratories Nucleic Acid Blood Screening Product Portfolio
6.10.5 Bio-Rad Laboratories Recent Developments/Updates
6.11 Horiba
6.11.1 Horiba Corporation Information
6.11.2 Horiba Nucleic Acid Blood Screening Description and Business Overview
6.11.3 Horiba Nucleic Acid Blood Screening Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Horiba Nucleic Acid Blood Screening Product Portfolio
6.11.5 Horiba Recent Developments/Updates
6.12 Thermo Fisher Scientific
6.12.1 Thermo Fisher Scientific Corporation Information
6.12.2 Thermo Fisher Scientific Nucleic Acid Blood Screening Description and Business Overview
6.12.3 Thermo Fisher Scientific Nucleic Acid Blood Screening Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Thermo Fisher Scientific Nucleic Acid Blood Screening Product Portfolio
6.12.5 Thermo Fisher Scientific Recent Developments/Updates
6.13 bioMerieux
6.13.1 bioMerieux Corporation Information
6.13.2 bioMerieux Nucleic Acid Blood Screening Description and Business Overview
6.13.3 bioMerieux Nucleic Acid Blood Screening Sales, Revenue and Gross Margin (2019-2024)
6.13.4 bioMerieux Nucleic Acid Blood Screening Product Portfolio
6.13.5 bioMerieux Recent Developments/Updates
6.14 Danaher
6.14.1 Danaher Corporation Information
6.14.2 Danaher Nucleic Acid Blood Screening Description and Business Overview
6.14.3 Danaher Nucleic Acid Blood Screening Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Danaher Nucleic Acid Blood Screening Product Portfolio
6.14.5 Danaher Recent Developments/Updates
6.15 Abbott
6.15.1 Abbott Corporation Information
6.15.2 Abbott Nucleic Acid Blood Screening Description and Business Overview
6.15.3 Abbott Nucleic Acid Blood Screening Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Abbott Nucleic Acid Blood Screening Product Portfolio
6.15.5 Abbott Recent Developments/Updates
6.16 BD
6.16.1 BD Corporation Information
6.16.2 BD Nucleic Acid Blood Screening Description and Business Overview
6.16.3 BD Nucleic Acid Blood Screening Sales, Revenue and Gross Margin (2019-2024)
6.16.4 BD Nucleic Acid Blood Screening Product Portfolio
6.16.5 BD Recent Developments/Updates
6.17 Mindray
6.17.1 Mindray Corporation Information
6.17.2 Mindray Nucleic Acid Blood Screening Description and Business Overview
6.17.3 Mindray Nucleic Acid Blood Screening Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Mindray Nucleic Acid Blood Screening Product Portfolio
6.17.5 Mindray Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nucleic Acid Blood Screening Industry Chain Analysis
7.2 Nucleic Acid Blood Screening Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nucleic Acid Blood Screening Production Mode & Process
7.4 Nucleic Acid Blood Screening Sales and Marketing
7.4.1 Nucleic Acid Blood Screening Sales Channels
7.4.2 Nucleic Acid Blood Screening Distributors
7.5 Nucleic Acid Blood Screening Customers
8 Nucleic Acid Blood Screening Market Dynamics
8.1 Nucleic Acid Blood Screening Industry Trends
8.2 Nucleic Acid Blood Screening Market Drivers
8.3 Nucleic Acid Blood Screening Market Challenges
8.4 Nucleic Acid Blood Screening Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Nucleic Acid Blood Screening Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Nucleic Acid Blood Screening Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Nucleic Acid Blood Screening Market Competitive Situation by Manufacturers in 2023
Table 4. Global Nucleic Acid Blood Screening Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Nucleic Acid Blood Screening Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Nucleic Acid Blood Screening Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Nucleic Acid Blood Screening Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Nucleic Acid Blood Screening Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Nucleic Acid Blood Screening, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Nucleic Acid Blood Screening, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Nucleic Acid Blood Screening, Product Type & Application
Table 12. Global Key Manufacturers of Nucleic Acid Blood Screening, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Nucleic Acid Blood Screening by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Blood Screening as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Nucleic Acid Blood Screening Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Nucleic Acid Blood Screening Sales by Region (2019-2024) & (K Units)
Table 18. Global Nucleic Acid Blood Screening Sales Market Share by Region (2019-2024)
Table 19. Global Nucleic Acid Blood Screening Sales by Region (2025-2030) & (K Units)
Table 20. Global Nucleic Acid Blood Screening Sales Market Share by Region (2025-2030)
Table 21. Global Nucleic Acid Blood Screening Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Nucleic Acid Blood Screening Revenue Market Share by Region (2019-2024)
Table 23. Global Nucleic Acid Blood Screening Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Nucleic Acid Blood Screening Revenue Market Share by Region (2025-2030)
Table 25. North America Nucleic Acid Blood Screening Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Nucleic Acid Blood Screening Sales by Country (2019-2024) & (K Units)
Table 27. North America Nucleic Acid Blood Screening Sales by Country (2025-2030) & (K Units)
Table 28. North America Nucleic Acid Blood Screening Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Nucleic Acid Blood Screening Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Nucleic Acid Blood Screening Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Nucleic Acid Blood Screening Sales by Country (2019-2024) & (K Units)
Table 32. Europe Nucleic Acid Blood Screening Sales by Country (2025-2030) & (K Units)
Table 33. Europe Nucleic Acid Blood Screening Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Nucleic Acid Blood Screening Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Nucleic Acid Blood Screening Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Nucleic Acid Blood Screening Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Nucleic Acid Blood Screening Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Nucleic Acid Blood Screening Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Nucleic Acid Blood Screening Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Nucleic Acid Blood Screening Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Nucleic Acid Blood Screening Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Nucleic Acid Blood Screening Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Nucleic Acid Blood Screening Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Nucleic Acid Blood Screening Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Nucleic Acid Blood Screening Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Nucleic Acid Blood Screening Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Nucleic Acid Blood Screening Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Nucleic Acid Blood Screening Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Nucleic Acid Blood Screening Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Nucleic Acid Blood Screening Sales (K Units) by Type (2019-2024)
Table 51. Global Nucleic Acid Blood Screening Sales (K Units) by Type (2025-2030)
Table 52. Global Nucleic Acid Blood Screening Sales Market Share by Type (2019-2024)
Table 53. Global Nucleic Acid Blood Screening Sales Market Share by Type (2025-2030)
Table 54. Global Nucleic Acid Blood Screening Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Nucleic Acid Blood Screening Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Nucleic Acid Blood Screening Revenue Market Share by Type (2019-2024)
Table 57. Global Nucleic Acid Blood Screening Revenue Market Share by Type (2025-2030)
Table 58. Global Nucleic Acid Blood Screening Price (US$/Unit) by Type (2019-2024)
Table 59. Global Nucleic Acid Blood Screening Price (US$/Unit) by Type (2025-2030)
Table 60. Global Nucleic Acid Blood Screening Sales (K Units) by Application (2019-2024)
Table 61. Global Nucleic Acid Blood Screening Sales (K Units) by Application (2025-2030)
Table 62. Global Nucleic Acid Blood Screening Sales Market Share by Application (2019-2024)
Table 63. Global Nucleic Acid Blood Screening Sales Market Share by Application (2025-2030)
Table 64. Global Nucleic Acid Blood Screening Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Nucleic Acid Blood Screening Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Nucleic Acid Blood Screening Revenue Market Share by Application (2019-2024)
Table 67. Global Nucleic Acid Blood Screening Revenue Market Share by Application (2025-2030)
Table 68. Global Nucleic Acid Blood Screening Price (US$/Unit) by Application (2019-2024)
Table 69. Global Nucleic Acid Blood Screening Price (US$/Unit) by Application (2025-2030)
Table 70. Roche Corporation Information
Table 71. Roche Description and Business Overview
Table 72. Roche Nucleic Acid Blood Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Roche Nucleic Acid Blood Screening Product
Table 74. Roche Recent Developments/Updates
Table 75. Grifols Diagnostic Solutions Corporation Information
Table 76. Grifols Diagnostic Solutions Description and Business Overview
Table 77. Grifols Diagnostic Solutions Nucleic Acid Blood Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Grifols Diagnostic Solutions Nucleic Acid Blood Screening Product
Table 79. Grifols Diagnostic Solutions Recent Developments/Updates
Table 80. PerkinElmer Corporation Information
Table 81. PerkinElmer Description and Business Overview
Table 82. PerkinElmer Nucleic Acid Blood Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. PerkinElmer Nucleic Acid Blood Screening Product
Table 84. PerkinElmer Recent Developments/Updates
Table 85. KHB Corporation Information
Table 86. KHB Description and Business Overview
Table 87. KHB Nucleic Acid Blood Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. KHB Nucleic Acid Blood Screening Product
Table 89. KHB Recent Developments/Updates
Table 90. Bacme Bio Corporation Information
Table 91. Bacme Bio Description and Business Overview
Table 92. Bacme Bio Nucleic Acid Blood Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Bacme Bio Nucleic Acid Blood Screening Product
Table 94. Bacme Bio Recent Developments/Updates
Table 95. Daan Gene Corporation Information
Table 96. Daan Gene Description and Business Overview
Table 97. Daan Gene Nucleic Acid Blood Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Daan Gene Nucleic Acid Blood Screening Product
Table 99. Daan Gene Recent Developments/Updates
Table 100. Wantai Biotechnology Corporation Information
Table 101. Wantai Biotechnology Description and Business Overview
Table 102. Wantai Biotechnology Nucleic Acid Blood Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Wantai Biotechnology Nucleic Acid Blood Screening Product
Table 104. Wantai Biotechnology Recent Developments/Updates
Table 105. Sansure Biotech Corporation Information
Table 106. Sansure Biotech Description and Business Overview
Table 107. Sansure Biotech Nucleic Acid Blood Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Sansure Biotech Nucleic Acid Blood Screening Product
Table 109. Sansure Biotech Recent Developments/Updates
Table 110. Zhuhai Livzon Reagents Corporation Information
Table 111. Zhuhai Livzon Reagents Description and Business Overview
Table 112. Zhuhai Livzon Reagents Nucleic Acid Blood Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Zhuhai Livzon Reagents Nucleic Acid Blood Screening Product
Table 114. Zhuhai Livzon Reagents Recent Developments/Updates
Table 115. Bio-Rad Laboratories Corporation Information
Table 116. Bio-Rad Laboratories Description and Business Overview
Table 117. Bio-Rad Laboratories Nucleic Acid Blood Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Bio-Rad Laboratories Nucleic Acid Blood Screening Product
Table 119. Bio-Rad Laboratories Recent Developments/Updates
Table 120. Horiba Corporation Information
Table 121. Horiba Description and Business Overview
Table 122. Horiba Nucleic Acid Blood Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Horiba Nucleic Acid Blood Screening Product
Table 124. Horiba Recent Developments/Updates
Table 125. Thermo Fisher Scientific Corporation Information
Table 126. Thermo Fisher Scientific Description and Business Overview
Table 127. Thermo Fisher Scientific Nucleic Acid Blood Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Thermo Fisher Scientific Nucleic Acid Blood Screening Product
Table 129. Thermo Fisher Scientific Recent Developments/Updates
Table 130. bioMerieux Corporation Information
Table 131. bioMerieux Description and Business Overview
Table 132. bioMerieux Nucleic Acid Blood Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. bioMerieux Nucleic Acid Blood Screening Product
Table 134. bioMerieux Recent Developments/Updates
Table 135. Danaher Corporation Information
Table 136. Danaher Description and Business Overview
Table 137. Danaher Nucleic Acid Blood Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Danaher Nucleic Acid Blood Screening Product
Table 139. Danaher Recent Developments/Updates
Table 140. Abbott Corporation Information
Table 141. Abbott Description and Business Overview
Table 142. Abbott Nucleic Acid Blood Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Abbott Nucleic Acid Blood Screening Product
Table 144. Abbott Recent Developments/Updates
Table 145. BD Corporation Information
Table 146. BD Description and Business Overview
Table 147. BD Nucleic Acid Blood Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. BD Nucleic Acid Blood Screening Product
Table 149. BD Recent Developments/Updates
Table 150. Mindray Corporation Information
Table 151. Mindray Description and Business Overview
Table 152. Mindray Nucleic Acid Blood Screening Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Mindray Nucleic Acid Blood Screening Product
Table 154. Mindray Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Nucleic Acid Blood Screening Distributors List
Table 158. Nucleic Acid Blood Screening Customers List
Table 159. Nucleic Acid Blood Screening Market Trends
Table 160. Nucleic Acid Blood Screening Market Drivers
Table 161. Nucleic Acid Blood Screening Market Challenges
Table 162. Nucleic Acid Blood Screening Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Nucleic Acid Blood Screening
Figure 2. Global Nucleic Acid Blood Screening Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Nucleic Acid Blood Screening Market Share by Type in 2023 & 2030
Figure 4. Blood Screening Equipment Product Picture
Figure 5. blood Screening Reagents Product Picture
Figure 6. Global Nucleic Acid Blood Screening Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Nucleic Acid Blood Screening Market Share by Application in 2023 & 2030
Figure 8. Blood Center
Figure 9. Central Blood Station
Figure 10. Central Blood Bank
Figure 11. Global Nucleic Acid Blood Screening Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Nucleic Acid Blood Screening Market Size (2019-2030) & (US$ Million)
Figure 13. Global Nucleic Acid Blood Screening Sales (2019-2030) & (K Units)
Figure 14. Global Nucleic Acid Blood Screening Average Price (US$/Unit) & (2019-2030)
Figure 15. Nucleic Acid Blood Screening Report Years Considered
Figure 16. Nucleic Acid Blood Screening Sales Share by Manufacturers in 2023
Figure 17. Global Nucleic Acid Blood Screening Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Nucleic Acid Blood Screening Players: Market Share by Revenue in 2023
Figure 19. Nucleic Acid Blood Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Nucleic Acid Blood Screening Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Nucleic Acid Blood Screening Sales Market Share by Country (2019-2030)
Figure 22. North America Nucleic Acid Blood Screening Revenue Market Share by Country (2019-2030)
Figure 23. United States Nucleic Acid Blood Screening Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Nucleic Acid Blood Screening Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Nucleic Acid Blood Screening Sales Market Share by Country (2019-2030)
Figure 26. Europe Nucleic Acid Blood Screening Revenue Market Share by Country (2019-2030)
Figure 27. Germany Nucleic Acid Blood Screening Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Nucleic Acid Blood Screening Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Nucleic Acid Blood Screening Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Nucleic Acid Blood Screening Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Netherlands Nucleic Acid Blood Screening Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Nucleic Acid Blood Screening Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Nucleic Acid Blood Screening Revenue Market Share by Region (2019-2030)
Figure 34. China Nucleic Acid Blood Screening Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Nucleic Acid Blood Screening Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Nucleic Acid Blood Screening Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Nucleic Acid Blood Screening Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Nucleic Acid Blood Screening Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Nucleic Acid Blood Screening Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Nucleic Acid Blood Screening Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Latin America Nucleic Acid Blood Screening Sales Market Share by Country (2019-2030)
Figure 42. Latin America Nucleic Acid Blood Screening Revenue Market Share by Country (2019-2030)
Figure 43. Mexico Nucleic Acid Blood Screening Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Brazil Nucleic Acid Blood Screening Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Argentina Nucleic Acid Blood Screening Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Colombia Nucleic Acid Blood Screening Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Nucleic Acid Blood Screening Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Nucleic Acid Blood Screening Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Nucleic Acid Blood Screening Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Nucleic Acid Blood Screening Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Nucleic Acid Blood Screening Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Nucleic Acid Blood Screening by Type (2019-2030)
Figure 53. Global Revenue Market Share of Nucleic Acid Blood Screening by Type (2019-2030)
Figure 54. Global Nucleic Acid Blood Screening Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Nucleic Acid Blood Screening by Application (2019-2030)
Figure 56. Global Revenue Market Share of Nucleic Acid Blood Screening by Application (2019-2030)
Figure 57. Global Nucleic Acid Blood Screening Price (US$/Unit) by Application (2019-2030)
Figure 58. Nucleic Acid Blood Screening Value Chain
Figure 59. Nucleic Acid Blood Screening Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
